drugset / Trial / NCT05247424

Pretreatment With Unfractionated Heparin for ST Elevation Myocardial Infarction

NCT05247424

Phase 4 Completed 600 enrolled University Medical Centre Ljubljana
RandomizedParallel-groupSingle-blindTreatment

Summary

Rupture of a coronary artery plaque leads to thrombotic occlusion of the coronary artery and would present as ST segment elevation myocardial infarction. Early treatment with aspirin and early primary percutaneous coronary intervention are indicated. Anticoagulation therapy, usually with unfractionated heparin, is required during percutaneous coronary intervention. Investigators hypothesis is that pretreatment with unfractionated heparin in addition to aspirin at first medical contact may facilitate spontaneous reperfusion of culprit artery and procedural thrombotic complication in patients with ST elevation myocardial infarction without significant risk of bleeding complications.

Timeline

Start
2022-03-10
Primary completion
2025-02-05
Completion
2025-03-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Heparin Other / unclassified 100 iu/kg Intravenous